Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SMS Pharmaceuticals Ltd Major Shareholding Notification 2020

Jun 23, 2020

62302_rns_2020-06-23_dd77bbeb-2b9a-40a7-8bc4-6bab1a8a6d19.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Date: 22.06.2020

From: Ramesh Babu Potluri Plot No: 26SQ, Road No:l0 Jubilee Hills Hyderabad - 500 033

To:

Listing Centre/Corporate Relation Department B S E Limited P J Towers, Dalal Street Mumbai : 400001

Scrip Code : 532815 Email: [email protected]; [email protected]

The Company Secretary SMS Pharmaceuticals Limited Plot No. 72, RNo: 8-2-334/3 & 4, Road No. 5 Opp. SBI Executive Enclave, Banjara Hills Hyderabad 500034.

Dear Sirs,

National Stock Exchange of India Limited "Exchange Plaza", Bandta-Kurla Complex Bandta East, Mumbai : 400051

Trading Symbol: SMSPHARMA Email: [email protected]

Asst. Vice President

Sub: Intimation under Regulation 10(5) of ti,e SEBI (SAS1) Regulation, 201l. Ref: Name of the Target Company: SMS Pharmaceuticals Limited - ISIN: INE812G01025

Intimation is hereby given, pursuant to Regulation 10(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulation, 2011, as amended, (hereinafter referred to "Regulations,) that I intend to acquire 26,50,000 (Twenty-six lakhs fifty thousand) equity shares (3.13%)of SMS Pharmaceuticals Limited ("Target Company'') on or after 26.06.2020 from Mrs. Annapuma Talluri. The said transaction is an inter-se transfer between members of Promoters/Promoters' Group / Persons acting in concert.

An advance intimation in the prescribed fonn as required under aforesaid regulation is enclosed herewitll for your information and records.

Thanking you,

YOT7 Ramesh Babu Potluri

Encl as above

Disclosures under Regulation 10(5) - Intimation to Stock Exchanges in respect of acquisition under Regulation 10(1)(a) ofSEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1. Name of the Target Company (fC) SMS Pharmaceuticals Limited ("Target Company' ')
CIN : 124239TG 1987PLC008066
2. Name of the acquirer(s) Ramesh Babu Potluri
3. Whether the acquirer(s ) is/
are
promoters of ti,e TC prior to me Yes
of
If
transaction.
not,
nature
Promoter & Promoter Group
relationship or association wim the Persons acting in concert
TC or its promoters
4. Details of the proposed acquisition
Name of ti,e person(s) from
a
Annapurna Talluri
whom shares are to be acquired
b Proposed date of acquisition Any time after 4 (four) working days from ti,e date of this intimation,
i.e. on or after Friday, June 26, 2020
c Number of shares to be 2650000 Equity Shares
acquired from each person
mentioned in 4(a) above
d Total shares to be acquired 3.13%
as % of share capital ofTC
e Price at which shares are Rs. 43.05 per share
. proposed to be acquired
f Rationale, if any, for the Inter-se transfer of equity shares of SMS Pharmaceuticals Ltd between
proposed transfer members of Promoter and Promo
ter Group Persons acting in concert
5. Relevant sub-clause of regulation Regulation 10(1)(a)(ii) of SEBI (Substantial Acquisition of Shares and
10(1)(a) under which me acquirer Takeovers) Regulations, 2011 as amended (''Takeover Regulations,
is exempted from making open 2011 ")
offer
frequently
traded,
volume
6. If,
weighted average market price for
Rs.43.05 per share (NSE)
a of 60
period
trading
days
preceding ti,e date of issuance of
tlus notice as traded on me stock
where
the
exchange
maXlmum
volume of trading in the shares of
the TC are recorded during such
period.
If in-frequently traded, the price as
7. determined in terms of clause (e) of Not applicable
sub-regulation (2) of regulation 8.
8. Declaration by the acquirer, that the
acquisition price would not be higher
25% of the
by
pnce
more
than
We hereby declare that the acquisition price is not higher by more
than 25% of the price computed in Point 6.
computed in point 6 or point 7 as
applicable.
9. Declaration by the acquirer, that the We hereby declare that the transferor and transferee have
transferor
and
have
transferee
complied /will comply with applicable disclosure requirements in
/
will
complied
comply
with
Chapter V of the Takeover Regulations, 2011.
applicable disclosure requirements in
of
Chapter
V
the
Takeover
Regulations,
2011
(corresponding
provisions of the repealed Takeover
Regulations 1997)
10. Declaration by the acquirer tllat all the We hereby declare that all the conditions specified under
conditions specified under regulation Regulation 10(1)(a) of the takeover Regulations, with respect to
10(1)(a) with respect to exemptions exemptions have
been duly complied with,
to
the extent
has been duly complied with. applicable.
11. Shareholding details Before the proposed After the proposed transaction
transaction
No. of % w.r.t. No. of 0/0 w.r.t.
shares/Voting total share shares /V oting total share
rights capital of rights capital of
a. Acquirer(s) and PACs (other than 41106330 TC
48.56%
43756330 TC
51.69
sellers) (*)
b. Seller (s) 15859020 18.73% 13209020 15.60

RAME UPOTLURI Promoter of Target Company

Date: 22.06.2020 Place: Hyderabad